1054 related articles for article (PubMed ID: 25425969)
1. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
2. Sox4 is a master regulator of epithelial-mesenchymal transition by controlling Ezh2 expression and epigenetic reprogramming.
Tiwari N; Tiwari VK; Waldmeier L; Balwierz PJ; Arnold P; Pachkov M; Meyer-Schaller N; Schübeler D; van Nimwegen E; Christofori G
Cancer Cell; 2013 Jun; 23(6):768-83. PubMed ID: 23764001
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
4. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
[TBL] [Abstract][Full Text] [Related]
5. Core needle biopsy promotes lung metastasis of breast cancer: An experimental study.
Fu Y; Guo F; Chen H; Lin Y; Fu X; Zhang H; Ding M
Mol Clin Oncol; 2019 Feb; 10(2):253-260. PubMed ID: 30680204
[TBL] [Abstract][Full Text] [Related]
6. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
7. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674
[TBL] [Abstract][Full Text] [Related]
8. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models.
Bockhorn J; Prat A; Chang YF; Liu X; Huang S; Shang M; Nwachukwu C; Gomez-Vega MJ; Harrell JC; Olopade OI; Perou CM; Liu H
Cancer Res; 2014 Dec; 74(24):7406-17. PubMed ID: 25339353
[TBL] [Abstract][Full Text] [Related]
9. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
Hamilton G; Rath B
Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
[TBL] [Abstract][Full Text] [Related]
12. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.
Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP
Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085
[TBL] [Abstract][Full Text] [Related]
14. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY
Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560
[TBL] [Abstract][Full Text] [Related]
15. Core-needle biopsy of breast cancer is associated with a higher rate of distant metastases 5 to 15 years after diagnosis than FNA biopsy.
Sennerstam RB; Franzén BSH; Wiksell HOT; Auer GU
Cancer Cytopathol; 2017 Oct; 125(10):748-756. PubMed ID: 28837268
[TBL] [Abstract][Full Text] [Related]
16. SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice.
Hamilton MJ; Halvorsen EC; LePard NE; Bosiljcic M; Ho VW; Lam V; Banáth J; Bennewith KL; Krystal G
Oncotarget; 2016 Jan; 7(4):3677-91. PubMed ID: 26683227
[TBL] [Abstract][Full Text] [Related]
17. A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells.
Meyer-Schaller N; Tiede S; Ivanek R; Diepenbruck M; Christofori G
Oncogene; 2020 Jun; 39(24):4728-4740. PubMed ID: 32404986
[TBL] [Abstract][Full Text] [Related]
18. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model.
Monterroza L; Parrilla MM; Samaranayake SG; Rivera-Rodriguez DE; Yoon SB; Bommireddy R; Hosten J; Barragan LC; Marcus A; Dobosh BS; Selvaraj P; Tirouvanziam R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791429
[TBL] [Abstract][Full Text] [Related]
20. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
